Skip to content

Internet Mindfulness Meditation Intervention

Internet Mindfulness Meditation Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02655835
Acronym
IMMI
Enrollment
52
Registered
2016-01-14
Start date
2014-09-30
Completion date
2015-12-31
Last updated
2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress

Keywords

mindfulness, meditation, internet

Brief summary

Phase 1 will follow 40 subjects and hopes to address whether or not IMMI can increase meditation practice as compared to another meditation program. The study will last six weeks for both the IMMI group (20 subjects) and the Access group (20 subjects). Access groups will receive learning materials and guided meditations, but the implementation will be self-paced. Participants in the IMMI group will receive weekly learning sessions and be required to practice meditation every day. IMMI group participants will also receive a weekly reminder call from a member of the study staff and have access to technical support in the event of trouble with the online program. All subjects will complete online self-report questionnaires that measure quality of life, self-efficacy, mood, sleep, mindfulness, and perceived stress at baseline and at the end of the six-week intervention. Subjects will also be given a questionnaire at the end of the study gauging their satisfaction with the mindfulness program they participated in. Phase 2 will follow 80 subjects and hopes to address whether or not IMMI is acceptable to participants and demographic information about IMMI users. The study will be the same as noted above, but all subjects will be entered in the IMMI program. Differences in recruitment rates, drop out, and patient satisfaction between the IMMI and Access groups will be analyzed. IMMI's ability to change meditation behavior (i.e. increasing time or frequency of meditation sessions), and improve quality of life will be examined as well.

Detailed description

Participants will undergo the following: Week 0 - Telephone screening; Week 1 - Baseline Assessment; Week 2-Week 7 - Internet Mindfulness Meditation Intervention (or Access in Phase 1); Week 8 - Endpoint Assessment

Interventions

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 - 80 years old * Access to Computer and Internet * Can hear and understand instructions * Willing to accept randomization scheme and agrees to follow the study protocol

Exclusion criteria

* Significant acute medical illness that would decrease likelihood of study completion (self-report) * Significant, untreated depression, as assessed by CESD-5 \>20 during screening * Current daily meditation practice (≥ 5 min/day daily for at least 30 days in the last 6 months. Past practice not exclusionary but will be recorded)

Design outcomes

Primary

MeasureTime frameDescription
Enrollment rateWeek 0 - ScreeningNumber of participants who are eligible and enroll in the study
Participant satisfactionWeek 8 - Endpoint assessmentClient Satisfaction Questionnaire
Number of internet mindfulness meditation training sessions completedWeek 8 - Endpoint Assessment (after intervention is complete)There are a total of 6 internet training sessions, and participants are instructed to complete one per week (where Week 0 is screening, Week 1 is Baseline Assessment, Week 2 is Training 1, Week 3 is Training 2, Week 4 is Training 3, Week 5 is Training 4, Week 6 is Training 5, and Week 7 is Training 6) . At the time of the endpoint assessment (Week 8), the number of completed training sessions is tabulated.
Completion RateWeek 8 - Endpoint assessmentNumber of participants who complete the endpoint assessment.

Secondary

MeasureTime frameDescription
MindfulnessWeek 1 - Baseline assessment & Week 8 - Endpoint assessmentMeasured with Five Factor Mindfulness Questionnaire (FFMQ)
Quality of Life SF-36Week 1 - Baseline assessment & Week 8 - Endpoint assessmentMeasured with Short-Form Health Survey (SF-36) self-report measure
Perceived StressWeek 1 - Baseline assessment & Week 8 - Endpoint assessmentMeasured with perceived stress scale (PSS)
Self-efficacyWeek 1 - Baseline assessment & Week 8 - Endpoint assessmentMeasured with General Perceived Self Efficacy (GPSE) self-report questionnaire
MoodWeek 1 - Baseline assessment & Week 8 - Endpoint assessmentMeasured with Center for Epidemiological Studies Depression Scale (CESD) self-report questionnaire
SleepWeek 1 - Baseline assessment & Week 8 - Endpoint assessmentMeasured with Pittsburgh Sleep Quality Index (PSQI) self-report questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026